Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00695)

DIG Name
Shellac
DIG Function
Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent

Full List of Drug(s) Co-administrated with This DIG

19 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Alectinib DMP1I6Y Lung cancer [2C25.0] Alectinib Hydrochloride eq 150mg base capsule F23327
Cabozantinib DMIYDT4 Thyroid cancer [2D10] Cabozantinib S-Malate eq 80mg base capsule F23394
Cariprazine DMJYDVK Bipolar disorder [6A60] Cariprazine Hydrochloride eq 3mg base capsule F23398
Chlordiazepoxide DMTN5XI Anxiety disorder [6B00-6B0Z] Chlordiazepoxide Hydrochloride 5mg capsule F23403
Disopyramide DM5SYZP Ventricular arrhythmias [BC71] Disopyramide Phosphate eq 100mg base capsule F23427
Elagolix sodium DMRDUC0 Endometriosis [GA10] Elagolix Sodium 300 mg capsule F23728
Lefamulin DME6G97 Community-acquired pneumonia [CA40.Z] Lefamulin 600 mg tablet F23802
Lonafarnib DMGM2Z6 Hutchinson-Gilford progeria syndrome [LD2B] Lonafarnib 50 mg capsule F24392
Meclofenamate sodium DMNL98G Arthritis [FA20] Meclofenamate Sodium eq 50mg base capsule F23225
Migalastat DMFIQ2H Fabry disease [5C56.01] Migalastat 123 mg capsule F23229
Nortriptyline DM4KDYJ Depression [6A70-6A7Z] Nortriptyline Hydrochloride 50mg capsule F23495
Phenoxybenzamine DM8KSQH Malignant essential hypertension [BA00] Phenoxybenzamine Hydrochloride 10mg/capsule capsule F23514
Pralsetinib DMWU0I2 Non-small-cell lung cancer [2C25.Y] Pralsetinib 100 mg capsule F23262
Propantheline DM2EN6G Excessive sweating [EE00.Z] Propantheline Bromide 15mg tablet F23354
Rifampin DMA8J1G Tuberculosis [1B10-1B1Z] Rifampin 300mg capsule F23536
Simeprevir DMLUA9D Chronic HCV-1 infection [1E51.1] Simeprevir Sodium eq 150mg base capsule F23355
Talazoparib DM1KS78 Breast cancer [2C60-2C65] Talazoparib 0.25 mg capsule F24298
Tofacitinib DMBS370 Rheumatoid arthritis [FA20] Tofacitinib Citrate eq 22mg base extended release tablet F23570
Trientine DMD2WPG Inborn error of metabolism [5C50-5C59] Trientine Hydrochloride 250mg capsule F23591
------------------
⏷ Show the Full List of 19 Approved Drug(s)
2 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
MK-4827 DMLYGH4 Ovarian cancer [2C73] Niraparib Tosylate 100mg capsule F23352
Selumetinib DMC7W6R Melanoma [2C30] Selumetinib 25 mg capsule F23892
------------------